Cargando…

Acute Coronary Syndrome in the COVID-19 Era—Differences and Dilemmas Compared to the Pre-COVID-19 Era

The COVID-19 pandemic has led to numerous negative implications for all aspects of society. Although COVID-19 is a predominant lung disease, in 10–30% of cases, it is associated with cardiovascular disease (CVD). The presence of myocardial injury in COVID-19 patients occurs with a frequency between...

Descripción completa

Detalles Bibliográficos
Autores principales: Lasica, Ratko, Djukanovic, Lazar, Mrdovic, Igor, Savic, Lidija, Ristic, Arsen, Zdravkovic, Marija, Simic, Dragan, Krljanac, Gordana, Popovic, Dejana, Simeunovic, Dejan, Rajic, Dubravka, Asanin, Milika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181081/
https://www.ncbi.nlm.nih.gov/pubmed/35683411
http://dx.doi.org/10.3390/jcm11113024
_version_ 1784723679664406528
author Lasica, Ratko
Djukanovic, Lazar
Mrdovic, Igor
Savic, Lidija
Ristic, Arsen
Zdravkovic, Marija
Simic, Dragan
Krljanac, Gordana
Popovic, Dejana
Simeunovic, Dejan
Rajic, Dubravka
Asanin, Milika
author_facet Lasica, Ratko
Djukanovic, Lazar
Mrdovic, Igor
Savic, Lidija
Ristic, Arsen
Zdravkovic, Marija
Simic, Dragan
Krljanac, Gordana
Popovic, Dejana
Simeunovic, Dejan
Rajic, Dubravka
Asanin, Milika
author_sort Lasica, Ratko
collection PubMed
description The COVID-19 pandemic has led to numerous negative implications for all aspects of society. Although COVID-19 is a predominant lung disease, in 10–30% of cases, it is associated with cardiovascular disease (CVD). The presence of myocardial injury in COVID-19 patients occurs with a frequency between 7–36%. There is growing evidence of the incidence of acute coronary syndrome (ACS) in COVID-19, both due to coronary artery thrombosis and insufficient oxygen supply to the myocardium in conditions of an increased need. The diagnosis and treatment of patients with COVID-19 and acute myocardial infarction (AMI) is a major challenge for physicians. Often the presence of mixed symptoms, due to the combined presence of COVID-19 and ACS, as well as possible other diseases, nonspecific changes in the electrocardiogram (ECG), and often elevated serum troponin (cTn), create dilemmas in diagnosing ACS in COVID-19. Given the often-high ischemic risk, as well as the risk of bleeding, in these patients and analyzing the benefit/risk ratio, the treatment of patients with AMI and COVID-19 is often associated with dilemmas and difficult decisions. Due to delays in the application of the therapeutic regimen, complications of AMI are more common, and the mortality rate is higher.
format Online
Article
Text
id pubmed-9181081
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91810812022-06-10 Acute Coronary Syndrome in the COVID-19 Era—Differences and Dilemmas Compared to the Pre-COVID-19 Era Lasica, Ratko Djukanovic, Lazar Mrdovic, Igor Savic, Lidija Ristic, Arsen Zdravkovic, Marija Simic, Dragan Krljanac, Gordana Popovic, Dejana Simeunovic, Dejan Rajic, Dubravka Asanin, Milika J Clin Med Review The COVID-19 pandemic has led to numerous negative implications for all aspects of society. Although COVID-19 is a predominant lung disease, in 10–30% of cases, it is associated with cardiovascular disease (CVD). The presence of myocardial injury in COVID-19 patients occurs with a frequency between 7–36%. There is growing evidence of the incidence of acute coronary syndrome (ACS) in COVID-19, both due to coronary artery thrombosis and insufficient oxygen supply to the myocardium in conditions of an increased need. The diagnosis and treatment of patients with COVID-19 and acute myocardial infarction (AMI) is a major challenge for physicians. Often the presence of mixed symptoms, due to the combined presence of COVID-19 and ACS, as well as possible other diseases, nonspecific changes in the electrocardiogram (ECG), and often elevated serum troponin (cTn), create dilemmas in diagnosing ACS in COVID-19. Given the often-high ischemic risk, as well as the risk of bleeding, in these patients and analyzing the benefit/risk ratio, the treatment of patients with AMI and COVID-19 is often associated with dilemmas and difficult decisions. Due to delays in the application of the therapeutic regimen, complications of AMI are more common, and the mortality rate is higher. MDPI 2022-05-27 /pmc/articles/PMC9181081/ /pubmed/35683411 http://dx.doi.org/10.3390/jcm11113024 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Lasica, Ratko
Djukanovic, Lazar
Mrdovic, Igor
Savic, Lidija
Ristic, Arsen
Zdravkovic, Marija
Simic, Dragan
Krljanac, Gordana
Popovic, Dejana
Simeunovic, Dejan
Rajic, Dubravka
Asanin, Milika
Acute Coronary Syndrome in the COVID-19 Era—Differences and Dilemmas Compared to the Pre-COVID-19 Era
title Acute Coronary Syndrome in the COVID-19 Era—Differences and Dilemmas Compared to the Pre-COVID-19 Era
title_full Acute Coronary Syndrome in the COVID-19 Era—Differences and Dilemmas Compared to the Pre-COVID-19 Era
title_fullStr Acute Coronary Syndrome in the COVID-19 Era—Differences and Dilemmas Compared to the Pre-COVID-19 Era
title_full_unstemmed Acute Coronary Syndrome in the COVID-19 Era—Differences and Dilemmas Compared to the Pre-COVID-19 Era
title_short Acute Coronary Syndrome in the COVID-19 Era—Differences and Dilemmas Compared to the Pre-COVID-19 Era
title_sort acute coronary syndrome in the covid-19 era—differences and dilemmas compared to the pre-covid-19 era
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181081/
https://www.ncbi.nlm.nih.gov/pubmed/35683411
http://dx.doi.org/10.3390/jcm11113024
work_keys_str_mv AT lasicaratko acutecoronarysyndromeinthecovid19eradifferencesanddilemmascomparedtotheprecovid19era
AT djukanoviclazar acutecoronarysyndromeinthecovid19eradifferencesanddilemmascomparedtotheprecovid19era
AT mrdovicigor acutecoronarysyndromeinthecovid19eradifferencesanddilemmascomparedtotheprecovid19era
AT saviclidija acutecoronarysyndromeinthecovid19eradifferencesanddilemmascomparedtotheprecovid19era
AT risticarsen acutecoronarysyndromeinthecovid19eradifferencesanddilemmascomparedtotheprecovid19era
AT zdravkovicmarija acutecoronarysyndromeinthecovid19eradifferencesanddilemmascomparedtotheprecovid19era
AT simicdragan acutecoronarysyndromeinthecovid19eradifferencesanddilemmascomparedtotheprecovid19era
AT krljanacgordana acutecoronarysyndromeinthecovid19eradifferencesanddilemmascomparedtotheprecovid19era
AT popovicdejana acutecoronarysyndromeinthecovid19eradifferencesanddilemmascomparedtotheprecovid19era
AT simeunovicdejan acutecoronarysyndromeinthecovid19eradifferencesanddilemmascomparedtotheprecovid19era
AT rajicdubravka acutecoronarysyndromeinthecovid19eradifferencesanddilemmascomparedtotheprecovid19era
AT asaninmilika acutecoronarysyndromeinthecovid19eradifferencesanddilemmascomparedtotheprecovid19era